Liu Xiaoming1, Kong Xiangchuang1, Lei Ziqiao1, Zhang Xiaoyong2, and Liu Dingxi1
1Departments of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 2MR Collaborations, Siemens Healthcare Ltd, Shenzhen, China
Synopsis
Contrast-enhanced
magnetic resonance angiography (CE-MRA) is the main modality used for assessing
carotid artery stenosis in the vessel lumen, but limited to the susceptibility
artifact, which would result in artifactual stenosis of artery adjacent to the
subclavian vein on the injection side of contrast medium. This study aims to
explore the quantitative influence of different injected flow rates of contrast
medium on the susceptibility effect in the subclavian arterial image of CE-MRA on
a 3T MR scanner. The result indicated that the magnetic susceptibility artifact
can be reduced by improving the injection speed of contrast agent
Introduction
Carotid
artery stenosis, induced by carotid atheromatous plaques has a relatively high
morbidity in most cases(1). Currently, contrast-enhanced magnetic
resonance angiography (CE-MRA) is the main modality used for assessing carotid
artery stenosis in the vessel lumen(2-4), but limited to the susceptibility
artifact due to its sensitivity to the T2* shortening effect with three-dimensional
spoiled gradient echo sequence (3D-GRE),which would result in artifactual
stenosis of artery adjacent to the
subclavian vein on the injection side of contrast medium.(5). This
study aims to explore the quantitative influence of different injected flow rates of contrast
medium on the susceptibility effect in the subclavian arterial image of CE-MRA on
a 3T MR scanner.Methods
All the
IRB-approved MR examinations were performed on a 3 Tesla MR scanner (Magnetom
Skyra, Siemens Medical Solution,Erlangen, Germany) using commercially available
12-channel head coil and 8-channel neck phased-array coil. 80 patients excluded with cardiac
insufficiency were enrolled in this study and randomly separated into 4 groups (A,
B, C, and D) to undergo neck contrast-enhanced MR examination. All patients
underwent carotid artery real-time bolus tracking using CARE bolus system, and Care
bolus examination was performed based on the vascular scout view to measure the
relationship between time and signal intensity.
An electronic
power injector (Spectris; Medrad, Pittsburgh, Pa) was used for contrast
material injection with 20 ml of Magnevist solution (Magnevist, 0.5 mmol/ml),
and 15 ml of normal saline via the right ulnar vein. The injection rate for the
defined four groups were 1 ml/s for group A, 2 ml/s for group B, 3 ml/s for
group C, and 4 ml/s for group D. Coronal MR examinations was performed with the
contrast agents at different injection rates using the following parameters: TR=44.3
ms, TE=1.56 ms, bandwidth=400 Hz/pixel, FOV=400 mm, slice thickness=40 mm, flip
angle =25° , imaging matrix =256x180.
The time-signal intensity curve of the couple subclavian arteries, subclavian
vein, and the carotid artery were obtained. The duration of susceptibility
effect of subclavian arteries and its ipsilateral veins during intravenous
injection were calculated, and the reference time of susceptibility effect
disappearance (Trel) was measured for comparison. The
difference in the susceptibility effect at different injected rates of contrast
medium was determined using One-way ANOVA variance analysis. Statistical
significance was defined as p < 0.05.Results
As
the injection rate of contrast medium was increased from 1.0 ml/s to 4.0 ml/s, there
were significant differences at the duration of susceptibility effect at
subclavian arteries among these 4 groups (p<0.01)(Table 1). Furthermore, there
was a negative correlation between the duration of susceptibility effect and
the rate of injection (Correlation coefficient rs =-0.918, p<0.001)(Fig 3). There were significant differences in reference time (Trel)
among the 4 groups at different injected rates of contrast medium (p<0.01), and while the
injection rate was higher, the reference time Trel was smaller(Fig 1).
Furthermore, the susceptibility artifact can be reduced with the injection of contrast
agent at the injected rate ≥3ml/s(Fig 2).Discussion and Conclusion
The susceptibility artifact that caused false positive stenosis isolated
to the subclavian artery in carotid artery CE-MRA was due to the highly
concentrated gadolinium in the adjacent subclavian vein. This study sought to study
the influence of the first-pass magnetic susceptibility artifact in neck CE-MRA using
care bolus analysis, which clearly revealed the influential mechanism of the magnetic
susceptibility artifact. The result indicated that the magnetic susceptibility
artifact can be reduced by improving the injection speed of contrast agent, and
the injected rate over 3 ml/s could obviously improve the issues of the
first-pass magnetic susceptibility effect. Characterized with its excellent
operability, repeatability and practicability, its application for controlling
image quality can be promoted.Acknowledgements
Many thanks to MR Collaborations, Siemens
Healthcare, Shenzhen, China.Many thanks to Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.
References
1.Rothwell PM, Coull AJ, Silver LE, et
al. Population-based study of event-rate, incidence, case fatality, and
mortality for all acute vascular events in all arterial territories (Oxford
Vascular Study). Lancet 2005;366(9499):1773-1783.
2.Momjian-Mayor
I, Burkhard P, Murith N, et al. Diagnosis of and treatment for symptomatic
carotid stenosis: an updated review. Acta Neurol Scand 2012;126(5):293-305.
3.Kakisis
JD, Avgerinos ED, Antonopoulos CN, Giannakopoulos TG, Moulakakis K, Liapis CD.
The European Society for Vascular Surgery guidelines for carotid intervention:
an updated independent assessment and literature review. Eur J Vasc Endovasc
Surg 2012;44(3):238-243.
4.Zhang
H, Maki JH, Prince MR. 3D contrast-enhanced MR angiography. J Magn Reson
Imaging 2007;25(1):13-25.
5.Anzalone
N, Scotti R, Iadanza A. MR angiography of the carotid arteries and intracranial
circulation: advantage of a high relaxivity contrast agent. Neuroradiology
2006;48 Suppl 1:9-17.